Search research articles
Contact Us
Filters
Showing results (681-690 of 737) with videos related to
Page
of 74
Sort By:
Molecular Cell
|
December 4, 2024
DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states
Yanqing Liu, Joel A Hrit, Alison A Chomiak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy
Brynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Blood
|
May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
Marianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR
Kole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
Cancer Research
|
August 2, 2017
FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A
Mamoru Takada, Weiguo Zhang, Aussie Suzuki, et al.
The American Journal of Surgical Pathology
|
April 14, 2009
Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody
Herbert Haack, Laura A Johnson, Christopher J Fry, et al.
Blood Advances
|
August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
Aiman J Faruqi, John A Ligon, Paul Borgman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Blood Advances
|
January 4, 2018
Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways
Sheryl M Gough, Liat Goldberg, Marbin Pineda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 11, 2019
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics
Sandhya R Panch, Sandeep K Srivastava, Nasha Elavia, et al.
Page
of 74
Search research articles
Search
Showing results (681-690 of 737) with videos related to
Sort By:
Page
of 74
Molecular Cell
|
December 4, 2024
DNA hypomethylation promotes UHRF1-and SUV39H1/H2-dependent crosstalk between H3K18ub and H3K9me3 to reinforce heterochromatin states
Yanqing Liu, Joel A Hrit, Alison A Chomiak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy
Brynn B Duncan, Steven L Highfill, Haiying Qin, et al.
Blood
|
May 27, 2016
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
Marianna Sabatino, Jinhui Hu, Michele Sommariva, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 26, 2025
Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR
Kole R DeGolier, Catherine Pham-Danis, Samuel D Burciaga, et al.
Cancer Research
|
August 2, 2017
FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A
Mamoru Takada, Weiguo Zhang, Aussie Suzuki, et al.
The American Journal of Surgical Pathology
|
April 14, 2009
Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody
Herbert Haack, Laura A Johnson, Christopher J Fry, et al.
Blood Advances
|
August 8, 2022
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
Aiman J Faruqi, John A Ligon, Paul Borgman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies
Rachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
Blood Advances
|
January 4, 2018
Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways
Sheryl M Gough, Liat Goldberg, Marbin Pineda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 11, 2019
Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics
Sandhya R Panch, Sandeep K Srivastava, Nasha Elavia, et al.
Page
of 74